Endoscopy News and Research

RSS

JMC Professor wins Karl Storz Lifetime Achievement Award in Endourology

Demetrius H. Bagley, M.D., the Nathan Lewis Hatfield Professor of Urology in the Department of Urology at Jefferson Medical College (JMC) of Thomas Jefferson University was recently honored as the 2010 recipient of the Karl Storz Lifetime Achievement Award in Endourology at the World Congress of Endourology. He is also a full Professor of Radiology.

28 Oct 2010

Epigenomics presents data on Septin9 biomarker clinical study for colorectal cancer at UEGW

Epigenomics AG, the cancer diagnostics company, announced that new data obtained in a clinical study with the Company's proprietary Septin9 biomarker for the blood-based detection of colorectal cancer, were presented yesterday at the 18th United European Gastroenterology Week (UEGW) in Barcelona, Spain.

28 Oct 2010

NeedleTech increases production area with new 73,000-square foot manufacturing facility

U.S. Congressman James McGovern, State Representative Elizabeth Poirier and local dignitaries joined Theragenics Corporation executives in ribbon cutting ceremonies on October 15 for a new 73,000-square foot manufacturing facility for the company's subsidiary, NeedleTech Products. The new facility increases NeedleTech's production area by 30% or 20,000 square feet, allowing the company to consolidate two separate older facilities into one location. The new building will allow NeedleTech to expand operations, increase R&D and offer more services to its customers.

25 Oct 2010

WallFlex Biliary RX Stent receives CE Mark approval for benign biliary strictures

Boston Scientific Corporation today announced that its WallFlex Biliary RX Fully Covered Stent has received CE Mark approval for the treatment of benign biliary strictures.

25 Oct 2010

Hepatitis C from anesthetist case assumes new proportions

According to Victoria’s chief health officer yesterday, another 1,100 people would be screened for hepatitis C that could have come from contact with an infected doctor at more than one clinic.

24 Oct 2010

Boston Scientific's Advanix Biliary Plastic Stents receive FDA 510(k) clearance and CE Mark approval

Boston Scientific Corporation today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration and CE Mark approval to market its Advanix™ Biliary Plastic Stents for the treatment of biliary strictures, including biliary stone disease, benign biliary strictures, and suspected and confirmed malignancies in the biliary system. The product is now available in Europe and other international markets; the Company plans to launch it in the U.S. this quarter.

21 Oct 2010

$OptiNose reports positive results from study of fluticasone delivered by novel device in refractory CRS$

OptiNose reports positive results from study of fluticasone delivered by novel device in refractory CRS

Today OptiNose Inc. announced the positive results of a study evaluating the efficacy of fluticasone when delivered by the Company's novel bi-directional technology in patients with refractory chronic rhinosinusitis (CRS). The results of the study have been published in an article in the September issue of Rhinology.

21 Oct 2010

Nexcore announces acquisition of Meditron product line from CooperSurgical

Nexcore Technologies, Inc. of Waldwick, an original equipment manufacturer of medical devices, today announced it has acquired the Meditron line of gastroenterology endoscopy products from CooperSurgical, Inc. of Trumbull, CT.

21 Oct 2010

Z-Medica enters agreement with two Swedish medical device distributors for QuikClot products

Z-Medica Corporation, a medical device company developing innovative hemostatic agents, today announced that it has signed exclusive distribution agreements with Vingmed AB and Mediplast AB, two leading Swedish medical device distributors, for distribution of its QuikClot line of hemostatic agents in Sweden, Denmark and Norway for the first time.

From Medica Corporation 21 Oct 2010

U.S. patient monitoring market to reach $4 billion by 2017: iData Research

According to a new report by iData Research the leading global authority in medical device and pharmaceutical market research, the U.S. patient monitoring market is expected to reach almost $4 billion by 2017.

19 Oct 2010

ACG 75th Scientific Meeting to review advances in gastrointestinal research, treatment of digestive diseases

Many of the world's preeminent gastroenterologists will gather for the American College of Gastroenterology's (ACG) 75th Annual Scientific Meeting at the Henry B. Gonzalez Convention Center in San Antonio, Texas starting Monday October 18, 2010, to review the latest scientific advances in gastrointestinal research, treatment of digestive diseases and clinical practice management.

19 Oct 2010

Study reveals diagnostic strategies eliminate ionizing radiation exposure in IBD patients

At the American College of Gastroenterology's (ACG) 75th Annual Scientific meeting in San Antonio, Texas, several studies of the effectiveness of non-X-ray techniques to evaluate Crohn's disease revealed that diagnostic strategies such as capsule endoscopy (CE) and magnetic resonance enteroscopy (MRE) are useful in managing patients with inflammatory bowel disease (IBD) and avoiding ionizing radiation.

19 Oct 2010

Salix presents two Phase 3 pivotal clinical trials data for non-C IBS at ACG Meeting

Salix Pharmaceuticals, Ltd. today announced the presentation of two analyses of data from its Phase 3 pivotal clinical trials, TARGET 1 and 2, demonstrating a 14-day course of XIFAXAN 550 mg (rifaximin) taken three times daily achieved adequate relief of symptoms of non-constipation irritable bowel syndrome (non-C IBS) in a significantly greater proportion of patients compared with placebo.

19 Oct 2010

Nanotope enters agreement with Smith & Nephew to develop cartilage regeneration product

Arrowhead Research Corporation today announced that its portfolio company, Nanotope, Inc., has entered into an agreement with Smith & Nephew, Inc., a member of the Smith & Nephew plc group to develop a cartilage regeneration product for human healthcare markets using a subset of its proprietary regenerative medicine technology.

18 Oct 2010

Accellent expects net sales of $124.5 million to $125.5 million for fiscal third quarter 2010

Accellent Inc. a wholly owned subsidiary of Accellent Holdings Corp. today announced certain preliminary financial information for its fiscal third quarter ended September 30, 2010. Such information remains preliminary and subject to review by our independent public accountants.

18 Oct 2010

Series of pan-endoscopies show unparalleled ability to navigate intestinal tract

Spirus Medical, Inc. a leading developer of diagnostic and therapeutic advancement systems for gastroenterology announces a series of pan-endoscopies in an average time of 60 minutes, using a flexible endoscope with an integral drive to power a single use spiral component. The initial clinical series, which was conducted outside the U.S., showed unparalleled ability to navigate the intestinal tract.

18 Oct 2010

Crosstex International introduces customized surgical masks

Cantel Medical Corp., announced today the launch of a new, unique design of medical face masks - the SecureFit™ series by Crosstex International, a Cantel subsidiary and a leading U.S. manufacturer of medical face masks. The SecureFit™ series of masks addresses scientific research that points to poorly fitting masks as a major hindrance to their effectiveness.

15 Oct 2010

Caris Life Sciences presents new diagnostic data at ACG 2010

Caris Life Sciences, Inc., a leading biosciences company focused on enabling precise and personalized healthcare through the highest quality anatomic pathology, molecular profiling and blood-based diagnostic technologies, today announced upcoming highlights from the Company's presentations at the 2010 Annual Meeting of the American College of Gastroenterology ("ACG 2010") held in San Antonio, TX, October 15-20. In total, Caris was awarded 17 accepted abstracts, three of which are ACG Presidential Poster Award recipients.

15 Oct 2010

Accellent commences cash tender offer for outstanding 10½% Senior Subordinated Notes due 2013

Accellent Inc., a wholly-owned subsidiary of Accellent Holdings Corp., announced today that it has commenced a cash tender offer for any and all of the $295,000,000 aggregate principal amount of its outstanding 10½% Senior Subordinated Notes due 2013.

14 Oct 2010

Study finds hemostatic powder effective in treating 95% of patients with bleeding peptic ulcers

A new material similar to that used by the U.S. Military to treat traumatic injuries is showing promise as the next novel treatment for bleeding ulcers, a condition that commonly affects up to 15 per cent of adults, according to Hong Kong physician Dr. James Lau.

14 Oct 2010

Endoscopy News and Research

JMC Professor wins Karl Storz Lifetime Achievement Award in Endourology

Epigenomics presents data on Septin9 biomarker clinical study for colorectal cancer at UEGW

NeedleTech increases production area with new 73,000-square foot manufacturing facility

WallFlex Biliary RX Stent receives CE Mark approval for benign biliary strictures

Hepatitis C from anesthetist case assumes new proportions

Boston Scientific's Advanix Biliary Plastic Stents receive FDA 510(k) clearance and CE Mark approval

OptiNose reports positive results from study of fluticasone delivered by novel device in refractory CRS

Nexcore announces acquisition of Meditron product line from CooperSurgical

Z-Medica enters agreement with two Swedish medical device distributors for QuikClot products

U.S. patient monitoring market to reach $4 billion by 2017: iData Research

ACG 75th Scientific Meeting to review advances in gastrointestinal research, treatment of digestive diseases

Study reveals diagnostic strategies eliminate ionizing radiation exposure in IBD patients

Salix presents two Phase 3 pivotal clinical trials data for non-C IBS at ACG Meeting

Nanotope enters agreement with Smith & Nephew to develop cartilage regeneration product

Accellent expects net sales of $124.5 million to $125.5 million for fiscal third quarter 2010

Series of pan-endoscopies show unparalleled ability to navigate intestinal tract

Crosstex International introduces customized surgical masks

Caris Life Sciences presents new diagnostic data at ACG 2010

Accellent commences cash tender offer for outstanding 10½% Senior Subordinated Notes due 2013

Study finds hemostatic powder effective in treating 95% of patients with bleeding peptic ulcers

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News